• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Algorithm drops number of CTs for some strokes

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 7
Volume 32
Issue 7

An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke.

An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke. The study was performed by New York Presbyterian Hospital – Weill Cornell Medical Center researchers and included 60 patients.

The algorithm identifies the most appropriate points at which to detect vasospasm with CT angiography and CT perfusion imaging. A flow chart establishes imaging pathways and time frames.

With the new algorithm, the mean number of CT examinations per patient dropped from 7.8 to 5.8, a decrease of 25.6%, according to the investigators.

The number of CT perfusion exams per patient decreased 32.1% and overall cumulative radiation exposure decreased by 12.1%.

The results were published in the American Journal of Roentgenology (AJR 2010;195[1]:176-180).

Recent Videos
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.